Intranasal ketorolac for postoperative pain: a phase 3, double-blind, randomized study.

@article{Brown2009IntranasalKF,
  title={Intranasal ketorolac for postoperative pain: a phase 3, double-blind, randomized study.},
  author={Colin R. Brown and John E. Moodie and Eileen J Bisley and Lincoln J. Bynum},
  journal={Pain medicine},
  year={2009},
  volume={10 6},
  pages={
          1106-14
        }
}
OBJECTIVE Analgesic efficacy and tolerability of intranasal (IN) ketorolac was evaluated in postoperative patients in a randomized, double-blind, placebo-controlled study. METHODS Patients received IN ketorolac (31.5 mg) [DOSAGE ERROR CORRECTED] or placebo three times daily for up to 5 days, with access to morphine by patient controlled analgesia (PCA). Patients in a single-dose phase were removed from PCA 3 hours prior to the first study dose the day after surgery, and received a single IN… 

Figures and Tables from this paper

Intranasal ketorolac for acute postoperative pain
TLDR
Intranasal ketorolac was well tolerated and provided effective pain relief within 20 minutes with reduced opioid analgesia use and may have more relevance for use in outpatient settings and ambulatory surgery or fast-track surgical procedures.
Intranasal ketorolac for pain secondary to third molar impaction surgery: a randomized, double-blind, placebo-controlled trial.
  • G. Grant, D. Mehlisch
  • Medicine
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • 2010
Original article Intranasal ketorolac for acute postoperative pain
TLDR
Pain intensity difference indicated significantly better pain relief in the ketorolac group at 20 min after the first dose, indicating better analgesic efficacy compared to placebo, and quality of analgesia was rated significantly higher in thecarbamazepine group by 20 minutes after first dose.
Intranasal Ketorolac
TLDR
In adult patients with acute pain following major surgery, intranasal ketorolac 31.5mg three or four times daily for ≤5 days was generally well tolerated and most adverse events in clinical trials were considered to be of mild severity and transient in nature.
Comparison of analgesic effects of intravenous and intranasal ketorolac in patients with mandibular fracture-A Randomized Clinical Trial
TLDR
Application of intranasal ketorolac spray decreased pain after mandibular fracture surgery, especially at 8-hour interval after surgery, decreasing the need for opioids.
Is Intranasal Ketorolac Both Safe and Effective in Reducing Acute Postoperative Pain for Patients over 18 Years of Age That Require Inpatient Hospitalization
TLDR
All three studies demonstrated that intranasal ketorolac is both safe and effective in reducing pain postoperatively.
The comparison between postoperative analgesic effect of Morphine-Apotel and Ketorolac alone with intravenous patient control analgesia in patients candidate for plating surgery
TLDR
It is revealed that administration of non-opioid drugs has no advantage compared to opioids in controlling post-operative pain.
PATIENT-CONTROLLED INTRAVENOUS ANALGESIA WITH MORPHINE-APOTEL AND KETOROLAC IN PATIENT’S CANDIDATE FOR PLATING SURGERY: A COMPARISON BETWEEN ANALGESIC EFFECTS
TLDR
It is revealed that administration of non-opioid drugs has no advantage compared to opioids in controlling post-operative pain.
...
...

References

SHOWING 1-10 OF 23 REFERENCES
Comparison of Morphine, Ketorolac, and Their Combination for Postoperative Pain: Results from a Large, Randomized, Double-blind Trial
TLDR
Opioids are more efficacious analgesics than NSAIDs, although historic data for these two drugs yield similar numbers needed to treat.
The morphine sparing effect of ketorolac tromethamine
A randomised, double‐blind study of patients after upper abdominal surgery was undertaken to assess the analgesic efficacy of ketorolac tromethamine, a new, parenteral non‐steroidal anti‐inflammatory
Ketorolac improves recovery after outpatient anorectal surgery
TLDR
The addition of ketorolac (60 mg), either intravenous or injected with local anesthetics, reduces voiding problems and significantly decreases postoperative analgesic requirements in outpatients undergoing anorectal surgery.
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.
TLDR
Ketorolac is a strong analgesic with a tolerability profile which resembles that of other NSAIDs when used in accordance with current dosage guidelines, this drug provides a useful alternative, or adjuvant, to opioids in patients with moderate to severe pain.
The role of ketorolac in decreasing length of stay and narcotic complications in the postoperative pediatric orthopaedic patient.
TLDR
Ketorolac is a safe and effective means of controlling postoperative pain in the pediatric orthopaedic population while avoiding the troubling maleffects seen with the exclusive use of morphine.
Pharmacokinetics and Safety of Ketorolac Following Single Intranasal and Intramuscular Administration in Healthy Volunteers
TLDR
In ketorolac offers a therapeutic alternative to IM administration and may provide benefits in the clinical setting and dose proportionality was noted between the 15‐ and 30‐mg IN and IM dose levels.
Opioid Analgesics versus Ketorolac in Spine and Joint Procedures: Impact on Healthcare Resources
TLDR
Several recovery milestones, including time to first bowel movement, first oral intake, and first unassisted ambulation, were reached sooner in the ketorolac group, with a resultant shorter mean length of postoperative stay.
The effect of ketorolac on postoperative febrile episodes in patients after abdominal myomectomy.
TLDR
Treatment with ketorolac after abdominal myomectomy results in a statistically significant reduction in the rate of febrile episodes, compared with the saline solution-treated group.
Effects of Nonsteroidal Antiinflammatory Drugs on Patient-controlled Analgesia Morphine Side Effects: Meta-analysis of Randomized Controlled Trials
TLDR
A regression analysis yielded findings indicating that morphine consumption was positively correlated with the incidence of nausea and vomiting, andPruritus, urinary retention, and respiratory depression were not significantly decreased by NSAIDs.
...
...